Oaktree Acquisition Corp. III Life Sciences (OACCU) Operating Expenses (2025 - 2026)
Oaktree Acquisition Corp. III Life Sciences' (OACCU) quarterly Operating Expenses came in at $456538.0 in Q1 2026, up 2.64% YoY from $444802.0 in Q1 2025, and up 78.69% on a QoQ basis from $255496.0 in Q4 2025.
Oaktree Acquisition Corp. III Life Sciences (OACCU) Operating Expenses (2025 - 2026) Analysis & Trends
Oaktree Acquisition Corp. III Life Sciences (OACCU) has 2 years of Operating Expenses data on file, last reported at $456538.0 in Q1 2026.
- Quarterly Operating Expenses rose 2.64% year-over-year to $456538.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.2 million (changed N/A YoY) and the FY2025 annual result came in at $1.2 million, up 239.87% from the prior year.
- Operating Expenses advanced to $456538.0 in Q1 2026, from $255496.0 in the prior quarter.
- In the past five years, Operating Expenses ranged from a high of $456538.0 in Q1 2026 to a low of $225579.0 in Q3 2025.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 261,958.00 |
| Mar 31, 2026 | 456,538.00 |
| Dec 31, 2025 | 255,496.00 |
| Sep 30, 2025 | 225,579.00 |
| Jun 30, 2025 | 269,810.00 |
| Mar 31, 2025 | 444,802.00 |